Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.8300
+0.0466 (5.95%)
Sep 23, 2025, 1:01 PM EDT - Market open
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,631,721
Market Cap
7.85M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3 | 0 | - |
Dec 31, 2023 | 3 | 0 | - |
Dec 31, 2022 | 3 | 1 | 50.00% |
Dec 31, 2021 | 2 | 1 | 100.00% |
Dec 31, 2020 | 1 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SILO News
- 7 days ago - Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy - GlobeNewsWire
- 14 days ago - Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug - GlobeNewsWire
- 20 days ago - Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio - GlobeNewsWire
- 4 weeks ago - Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal - GlobeNewsWire
- 5 weeks ago - Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway - GlobeNewsWire
- 7 weeks ago - Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform - GlobeNewsWire
- 2 months ago - Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15 - GlobeNewsWire
- 2 months ago - Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025 - GlobeNewsWire